Dow Geoffrey S

President and CEO, Director60 DEGREES PHARMACEUTICALS, INC. (SXTP) · full profile →Form 4 · filed Nov 21, 2024
Net Buying
Open-Market Buys
$6K
Open-Market Sells
$0
Net Open-Market Flow
$6K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 21, 2024Buy(P)4K$0.91$3K21K
Nov 20, 2024Buy(P)1K$0.92$92017K
Nov 19, 2024Buy(P)3K$0.90$2K16K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-101110) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about SXTP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001213900-24-101110"
Ask your agent
Use Arkolith to summarize insider buying and selling at 60 DEGREES PHARMACEUTICALS, INC.
over the last 90 days and cite the filings.